Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC
Clinical trial NCT04663438 · UNKNOWN
Trial details
- NCT number
- NCT04663438
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-30
- Primary completion
- 2020-12-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.